scholarly journals Real‐world Australian data reflect very high sustained virologic response at 12 weeks with direct acting antiviral therapy for hepatitis C and suggests highly achievable even in those without an end‐of‐treatment response

2019 ◽  
Vol 49 (5) ◽  
pp. 666-669
Author(s):  
James Williams ◽  
Nicolas Lucarelli ◽  
Amanda Nicoll ◽  
John Lubel
Keyword(s):  
Hepatitis C ◽  
Antiviral Therapy ◽  
Real World ◽  
Sustained Virologic Response ◽  
Virologic Response ◽  
Direct Acting Antiviral ◽  
End Of Treatment ◽  
Direct Acting ◽  
High Sustained Virologic Response ◽  
Very High

scholarly journals Incidence and Impact of Persistent Viremia on SVR Rates in Patients Receiving Direct-Acting Antiviral Therapy

2020 ◽  
Vol 7 (12) ◽  
Author(s):  
Alicia B Carver ◽  
Autumn D Zuckerman ◽  
Joshua DeClercq ◽  
Leena Choi ◽  
Cody A Chastain
Keyword(s):  
Antiviral Therapy ◽  
Real World ◽  
Sustained Virologic Response ◽  
Response Rates ◽  
Virologic Response ◽  
Direct Acting Antiviral ◽  
Rapid Virologic Response ◽  
Persistent Viremia ◽  
Direct Acting ◽  
High Sustained Virologic Response

Abstract Rates of persistent viremia (PV) while on direct-acting antiviral therapy were low (5.7%) in a real-world cohort of 983 patients. High sustained virologic response rates were achieved both in patients with PV (92.9%) and those with rapid virologic response (96.5%), without significant differences.

Hepatitis C “true” late relapse beyond 48 weeks of sustained virologic response after direct acting antiviral therapy

2017 ◽  
Vol 66 (4) ◽  
pp. 862-863 ◽  
Author(s):  
Thomas Klag ◽  
Julia Dietz ◽  
Christoph R. Werner ◽  
Julia M. Schwarz ◽  
Ulrich M. Lauer ◽  
...  
Keyword(s):  
Hepatitis C ◽  
Antiviral Therapy ◽  
Sustained Virologic Response ◽  
Virologic Response ◽  
Late Relapse ◽  
Direct Acting Antiviral ◽  
Direct Acting

New-onset hepatitis C virus-associated glomerulonephritis following sustained virologic response with direct-acting antiviral therapy

2017 ◽  
Vol 87 (05) ◽  
pp. 261-266 ◽  
Author(s):  
Muriel Ghosn ◽  
Matthew Palmer ◽  
Catherine Najem ◽  
Danny Haddad ◽  
Peter Merkel ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Antiviral Therapy ◽  
Sustained Virologic Response ◽  
Virologic Response ◽  
Direct Acting Antiviral ◽  
Direct Acting ◽  
New Onset
Sign in / Sign up

Export Citation Format

Share Document